New drug offers hope for rare swelling attacks
Symptom relief
Completed
This study tested a drug called icatibant (Icanticure) in 5 adults with a rare condition that causes sudden, painful swelling attacks. The drug is already approved for hereditary angioedema, but this study aimed to gather more safety and effectiveness data for patients who couldn…
Phase: PHASE4 • Sponsor: Nang Kuang Pharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated May 14, 2026 12:03 UTC